It should be considered that as with any hemocomponent, CP transfusion carries the risk of adverse reactions, such as non-hemolytic febrile reactions, allergic reactions, transfusion-associated infections, hemolytic reactions, and more severe reactions such as transfusion-related acute lung injury or transfusion-associated circulatory overload [44]. The gene discussed is CP; the disease is infection.